
(TEST) theMednet
Target Audience
Learning Objectives
At the conclusion of this activity, participants will be able to:
- Illustrate how cutting-edge data presented at the 2020 Annual Meeting of the American Society of Hematology (ASH) can apply to clinical practice, addressing best practices and guidelines;
- State the emerging treatment strategies for patients with low-risk and high-risk myeloid malignancies;
- Discuss the optimal patient selection, timing, and regimen for transplant;
- Evaluate clinical trial data in the context of CAR T-cell therapy and its place in evolving hematologic malignancy treatment standards;
- Choose the optimal treatment, sequencing, and supportive care strategies for patients with lymphoma using evidence-based guidelines;
- Identify methods for integrating therapeutic advances into practice to improve current myeloma patient care;
- Describe the pathogenesis, diagnostic evaluation, and therapeutic modalities available for common benign hematologic diseases.
- 20.00 AMA PRA Category 1 Credit™
- 20.00 Participation

WANT TO KNOW MORE?
Learn more about the conference by visiting the conference website here!
Questions?
Contact Meeting Achievements via e-mail here.
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact Meeting Achievements via e-mail via at support@meetingachievements.com.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
COURSE DIRECTOR
GUEST SPEAKER
MD Anderson Cancer Center
UNIVERSITY OF CHICAGO FACULTY
Benjamin A. Derman, MD Assistant Professor of Medicine | Adam Duvall, MD, MPH Assistant Professor of Medicine |
Andrzej Jakubowiak, MD, PhD Professor of Medicine Director, Myeloma Program | Satyajit Kosuri, MD Assistant Professor of Medicine |
Olatoyosi Odenike, MD Professor of Medicine | Peter A. Riedell, MD Assistant Professor of Medicine |
Sonali M. Smith, MD Chief, Section of Hematology/Oncology Director, Lymphoma Program Elwood V. Jensen Professor in Medicine | Michael J. Thirman, MD Associate Professor of Medicine |
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine designates this Internet point-of-care activity activity for a maximum of 20 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.
Registration: Registration for this activity is closed.
Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.